Stifel Financial Corp Accelerate Diagnostics, Inc Transaction History

Stifel Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$7.49 - $15.16 $9,654 - $19,541	-1,289 Reduced 11.42%	10,000 $152,000
Q1 2020 May 14, 2020	SELL	$4.62 - $18.74 $1.98 Million - $8.04 Million	-429,105 Reduced 97.44%	11,289 $95,000
Q4 2019 Feb 13, 2020	SELL	$14.6 - $18.13 $928,165 - $1.15 Million	-63,573 Reduced 12.61%	440,394 $7.42 Million
Q3 2019 Nov 13, 2019	SELL	$16.62 - $23.92 $2.23 Million - $3.21 Million	-134,087 Reduced 21.01%	503,967 $9.38 Million
Q2 2019 Aug 14, 2019	SELL	$17.79 - $22.88 $247,014 - $317,688	-13,885 Reduced 2.13%	638,054 $14.6 Million
Q1 2019 May 14, 2019	BUY	$11.76 - $22.15 $1.12 Million - $2.11 Million	95,176 Added 17.09%	651,939 $13.8 Million
Q4 2018 Feb 13, 2019	BUY	$10.42 - $21.94 $1.15 Million - $2.41 Million	110,034 Added 24.63%	556,763 $6.37 Million
Q3 2018 Nov 13, 2018	BUY	$20.4 - $24.6 $9.11 Million - $11 Million	446,729 New	446,729 $10.3 Million
Q4 2017 Feb 14, 2018	SELL	$18.0 - $30.0 $481,896 - $803,160	-26,772 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$21.1 - $25.15 $564,889 - $673,315	26,772	26,772 $0

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.